General practice pilot to ease ‘significant impacts’ of hay fever To boost low adherence to treatments, a new trial aims to support GPs through a tailored education toolkit used alongside daily nasal spray.
First Arexvy safety data released The Australian-first safety data found 63% of recipients experienced no side effects in the first three days after vaccination.
Calls for expanded genetic testing funding While the MBS item covering three conditions is welcome, experts say greater funding would boost access for more conditions and counselling.
Free RSV vaccination for Qld pregnant women Queensland’s expectant mothers are now eligible for a subsidised Abrysvo vaccination, as the state’s RSV cases soar to 40,000 in 2024.
RSV vaccine added to national program To ensure ‘every single infant in Australia is protected’, a $174.5 million investment will see free vaccines for pregnant people available nationwide.
Whooping cough epidemic reaches record numbers GPs are urged to ensure patients have had their vaccine, as ‘staggeringly high’ cases soar to a record-breaking 41,772 so far this year.
Victoria subsidises RSV immunisations for babies The State Government will fund the long-acting monoclonal antibody for unprotected newborns and eligible infants next winter.
Government defers CDM Medicare item changes The concerns of GPs have been listened to, resulting in the Commonwealth delaying chronic disease management funding changes to 1 July next year.
Subsidised RSV vaccines for SA infants The State Government will roll out the new program in winter next year, with subsidised vaccines for unprotected newborns and high-risk children.
‘Extremely concerned’: Frustration boils over amid CDM uncertainty The RACGP has demanded the Federal Government delay chronic disease management changes until funding details are clarified.